Cargando…
Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
Colorectal cancer (CRC) is the third most commonly diagnosed cancer. Celastrol exhibits anti-tumor activities in a variety of cancers. However, the effect of Celastrol on human CRC and the underlying mechanisms still need to be elucidated. The present study aimed to use in vitro and in vivo methods...
Autores principales: | Xiao-pei, Huang, Ji-kuai, Chen, Xue, Wei, Dong, Yi-Fan, Yan, Lang, Xiao-fang, Zhang, Ya-min, Pan, Wen-jun, Chang, Jiang-bo, Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246769/ https://www.ncbi.nlm.nih.gov/pubmed/30333251 http://dx.doi.org/10.1042/BSR20181233 |
Ejemplares similares
-
Correction: Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol
Publicado: (2021) -
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015) -
Quantitative Proteomics Reveals Cellular Targets of Celastrol
por: Hansen, Jakob, et al.
Publicado: (2011) -
Regulating mitochondrial homeostasis and inhibiting inflammatory responses through Celastrol
por: Tao, Zhenyu, et al.
Publicado: (2022) -
Formulation and Evaluation of Celastrol-Loaded Liposomes
por: Song, Jie, et al.
Publicado: (2011)